Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Notice of transfer of equity shares of the Company to Investor Education and Protection Fund ('IEPF')01-07-2022
01-07-2022
Jubilant Pharmova Ltd - 530019 - Appointment of Company Secretary and Compliance Officer
Appointment of Mr. Naresh Kapoor as Company Secretary and Compliance Officer effective from August 1, 2022 and superannuation of Mr. Rajiv Shah, Company Secretary and Compliance Officer from the close of business hours of July 31, 2022.01-07-2022
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. R. Kumar as an Additional Director and Whole-time Director and resignation of Mr. Pramod Kumar as Director of the Company01-07-2022
Jubilant Pharmova Ltd - 530019 - Jubilant Hollisterstier General Partnership, A Subsidiary Of The Company, Announcing CAD 100 Million Expansion Of Its CMO Manufacturing Facility At Montreal, Canada And Government Of Quebec Funding Of CAD 25 Million Through A Loan.
Jubilant HollisterStier General Partnership, a subsidiary of the Company, announcing CAD 100 Million expansion of its CMO manufacturing facility at Montreal, Canada and Government of Quebec funding of CAD 25 Million through a loan.30-06-2022
Jubilant Pharmova Ltd - 530019 - Closure of Trading Window
Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for the 'Designated Persons' from Friday, June 24, 2022 and the same shall remain closed till 48 hours after announcement of the financial results for the quarter ending June 30, 2022 to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. This is for your information and record.23-06-2022
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Receipt of NCLT''s formal order14-06-2022
Jubilant Pharmova Ltd - 530019 - Details Of Related Party Transactions For HYE March'' 2022
Details of Related Party Transactions for HYE March'' 202210-06-2022
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings conference call for the quarter and year ended March 31, 202202-06-2022
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investors/ Analysts Meeting31-05-2022
Earnings Call for Q4FY22 of Jubilant Pharmova
Conference Call with Jubilant Pharmova Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.28-05-2022